I am analyzing the differential expression of splicing variants, through capillary electrophoresis, of a DNA repair gene after treatment with a DNA-damaging drug. I am using gene-specific primers for cDNA synthesis, which makes it challenging to identify a suitable internal control. Using another region of the same gene might also be affected by the drug, while choosing a housekeeping gene would require a separate cDNA synthesis step and introduce variability. What would be the most appropriate internal control to ensure accurate normalization in this setup?

More Muhammad Abrar Yousaf's questions See All
Similar questions and discussions